The role of FOLFIRINOX in metastatic pancreatic cancer: A meta-analysis
B Zhang, F Zhou, J Hong, DM Ng, T Yang… - World Journal of …, 2021 - Springer
Background The prognosis of pancreatic cancer (PC) is extremely poor, and most patients
with metastatic PC still receive palliative care. Here, we report the efficacy and safety of …
with metastatic PC still receive palliative care. Here, we report the efficacy and safety of …
Molecular features and clinical management of hereditary pancreatic cancer syndromes and familial pancreatic cancer
A Kasuga, T Okamoto, S Udagawa, C Mori… - International Journal of …, 2022 - mdpi.com
Hereditary pancreatic cancers are caused by several inherited genes. Familial pancreatic
cancer is defined as pancreatic cancer arising in a patient with at least two first-degree …
cancer is defined as pancreatic cancer arising in a patient with at least two first-degree …
Huaier suppresses pancreatic cancer progression via activating cell autophagy induced ferroptosis
Z Zhu, X Wang, W Zhang, M Gong, S Zhang… - Frontiers in …, 2022 - frontiersin.org
Purpose The anti-tumour effect of Huaier has been demonstrated in a variety of tumours.
Ferroptosis is a newly identified type of programmed cell death accompanied by the …
Ferroptosis is a newly identified type of programmed cell death accompanied by the …
Proton pump inhibitors use and the risk of pancreatic cancer: evidence from eleven epidemiological studies, comprising 1.5 million individuals
Simple Summary Proton pump inhibitors are commonly prescribed medications for
gastrointestinal disorders, which bring gastric acid down to normal levels. However, the …
gastrointestinal disorders, which bring gastric acid down to normal levels. However, the …
Adherence to NCCN genetic testing guidelines in pancreatic cancer and impact on treatment
Abstract Introduction National Comprehensive Cancer Network (NCCN) 2019 Guidelines
recommend universal germline (GL) testing for patients (pts) with pancreatic cancer (PC) …
recommend universal germline (GL) testing for patients (pts) with pancreatic cancer (PC) …
Metabolic syndrome and risk of pancreatic cancer: a population‐based prospective cohort study
B Xia, Q He, Y Pan, F Gao, A Liu, Y Tang… - … journal of cancer, 2020 - Wiley Online Library
Metabolic syndrome (MetS) and its components may link to pancreatic cancer risk; however,
current epidemiological evidence is limited, and the potential mechanisms underlying the …
current epidemiological evidence is limited, and the potential mechanisms underlying the …
Global, regional, and national survey on the burden and quality of care of pancreatic cancer: a systematic analysis for the Global Burden of Disease study 1990–2017
Background Pancreatic cancer (PC) is among the most lethal cancers worldwide, and the
quality of care provided to PC patients is a vital public health concern. We aimed to …
quality of care provided to PC patients is a vital public health concern. We aimed to …
Combination immunotherapy using oncolytic virus for the treatment of advanced solid tumors
Oncolytic virus (OV) is a new therapeutic strategy for cancer treatment. OVs can selectively
infect and destroy cancer cells, and therefore act as an in situ cancer vaccine by releasing …
infect and destroy cancer cells, and therefore act as an in situ cancer vaccine by releasing …
Exercise medicine in the management of pancreatic cancer: a systematic review
The aim of this study was to examine the health-related effects of exercise in patients with
pancreatic cancer (PanCa) through a systematic review of current evidence. Studies were …
pancreatic cancer (PanCa) through a systematic review of current evidence. Studies were …
[HTML][HTML] Early prediction of pancreatic cancer from new-onset diabetes: An associazione Italiana oncologia medica (AIOM)/associazione medici diabetologi (AMD) …
M Gallo, V Adinolfi, L Morviducci, S Acquati, E Tuveri… - ESMO open, 2021 - Elsevier
Pancreatic cancer (PC) is a common cause of cancer-related death, due to difficulties in
detecting early-stage disease, to its aggressive behaviour, and to poor response to systemic …
detecting early-stage disease, to its aggressive behaviour, and to poor response to systemic …